Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Bharat Parenterals has scheduled an earnings conference call on May 19, 2026, at 3:00 PM IST. The call will discuss the company's operational and financial performance for Q4 and the full fiscal year 2026.
May 12 2026 09:05:00
Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Approving Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Recommendation Of Final Dividend On Equity Shares.
Bharat Parenterals' Board of Directors will convene on May 18, 2026, to review and approve the audited financial results for Q4 & FY26. The board will also consider recommending a final dividend for the financial year.
May 09 2026 14:05:00
Bharat Parenterals Ltd - 541096 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Bharat Parenterals confirmed it does not meet the criteria to be identified as a Large Corporate as per SEBI circulars for fund raising through debt securities. This means the company is exempt from certain mandatory debt market participation requirements for Large Corporates.
Apr 29 2026 12:04:00
Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Bharat Parenterals' subsidiary, Innoxel Lifesciences Pvt. Ltd., received 5 observations under Voluntary Action Indicated (VAI) from the U.S. FDA. The surprise inspection of its Vadodara finished dosage facility occurred from April 13-17 and April 20, 2026.
Apr 21 2026 13:04:00
Read More